Risk Manag
Without heavy, regular strength training and a high protein diet, you will end up as whats known as skinny fat i.e
Lawsuits against Novo Nordisk, the manufacturer of Ozempic, allege the pharmaceutical giant knew or should have known the drug carried a significant risk of harm for users
The good news from the study is that patients experienced improvements in blood pressure, total cholesterol level and HbA1c level, underscoring the products association with prevention of cardiovascular disease risks
In the UK, the pathway to approval typically involves: Submission of a Marketing Authorisation Application (MAA) to the MHRA Scientific review of clinical trial data, including safety, efficacy, and quality data Benefit-risk assessment by MHRA experts If approved, a subsequent NICE technology appraisal to determine whether the medicine represents value for money and should be made available within the NHS The MHRA also operates an Early Access to Medicines Scheme (EAMS) , which can allow patients with life-threatening or seriously debilitating conditions to access promising unlicensed medicines before full approval
Additional research is needed to better understand the long-term health outcomes, ideal patient selection and the full scope of risks and benefits for people with T1D who use these medications